(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLIA SCREEN IN-VITRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLIA SCREEN IN-VITRO

ST13

US500000086882541

Class

5, 10

Filing

86882541

Registration

5126036

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

01/18/2026

Trademark type

Word

Nice classes

5, 10

Filing date

01/21/2016

Registration date

01/17/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/17/2023

Last transaction

01/18/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

2016-04-00

First use in commerce

2016-04-00

Drawing code

4

Owner type

16

Owner location

Cumming, GA

Examiner

HENRY,NAKIA D

Law office

O20

Current location

TMO LAW OFFICE 129

Holders and representatives

Holders

TransMed Co, LLC

Representatives

Sonia Lakhany LAKHANY LAW

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids

Class 10

Multi-drug testing cups for drug use testing purposes; Untreated multi-drug testing dip cards for drug use testing purposes

Publications

History of USPTO decisions and trademark events.

27 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/17/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/01/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/01/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/01/2024

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

06/17/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

06/17/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/17/2023

ES8R

TEAS SECTION 8 RECEIVED

12/23/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/17/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/17/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/13/2016

ALIE

ASSIGNED TO LIE

12/13/2016

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

11/29/2016

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

11/28/2016

IUAA

USE AMENDMENT ACCEPTED

11/28/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/11/2016

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

11/11/2016

IUAF

USE AMENDMENT FILED

11/11/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2016

EAAU

TEAS AMENDMENT OF USE RECEIVED

11/10/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/10/2016

GNRT

NON-FINAL ACTION E-MAILED

05/10/2016

CNRT

NON-FINAL ACTION WRITTEN

05/10/2016

DOCK

ASSIGNED TO EXAMINER

05/05/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2016

NWAP

NEW APPLICATION ENTERED

01/25/2016

Continuous trademark protection

Get notified about every new filing that threatens CLIA SCREEN IN-VITRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.